Howard Lee - 01 Jun 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
01 Jun 2023
Transactions value $
-$472,588
Form type
4
Filing time
05 Jun 2023, 16:18:06 UTC
Previous filing
14 Jun 2022
Next filing
07 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $278K +16.7K +11.67% $16.69 160K 01 Jun 2023 Direct
transaction AMPH Common Stock Sale -$751K -16.7K -10.45% $45.02 143K 01 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -16.7K -100% $0.00* 0 01 Jun 2023 Common Stock 16.7K $16.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.80 to $45.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.